Mingliang Wang (Yongxiang Li)

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Yufeng Wang, David L Drum, Ruochuan Sun, Yida Zhang, Feng Chen, Fengfei Sun, Emre Dal, Ling Yu, Jingyu Jia, Shahrzad Arya, Lin Jia, Song Fan, Steven Jay Isakoff, Allison M Kehlmann, Gianpietro Dotti, Fubao Liu, Hui Zheng, Cristina R Ferrone, Alphonse G Taghian, Albert B DeLeo, Marco Ventin, Giulia Cattaneo, Mingliang Wang, Youssef Jounaidi, Peigen Huang, Cristina Maccalli, Hanyu Zhang, Cheng Wang, Jibing Yang, Genevieve Marie Boland, Ruslan I Sadreyev, LaiPing Wong, Soldano Ferrone, Xinhui Wang
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment. Nature communications 14 (1) (2023)
Mingliang Wang, Jing Li, Xiaodong Yang, Qiang Yan, Huizhen Wang, Xin Xu, Yida Lu, Deguan Li, Yigao Wang, Ruochuan Sun, Shangxin Zhang, Yonghong Zhang, Zhen Zhang, Futao Meng, Yong-Xiang Li
Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis. Cancer gene therapy (2023)
Mingliang Wang, Cheng Wu, Yida Lu, Xin Xu, Huizhen Wang, Youliang Wu, Xiaodong Wang, Yongxiang Li
Development and validation of a prognostic nomogram for gastric marginal zone lymphoma: a Surveillance, Epidemiology and End Results-based population study. Future oncology (London, England) 17 (5) (2021)

Mingliang Wang.css-eqlu8i{font-size:small;padding-left:4px;} (Yongxiang Li)